Ignite Creation Date:
2025-12-25 @ 1:17 AM
Ignite Modification Date:
2025-12-25 @ 11:26 PM
Study NCT ID:
NCT04958993
Status:
TERMINATED
Last Update Posted:
2022-02-25
First Post:
2020-08-25
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
A Trial of Anlotinib Combined With Concurrent Chemoradiotherapy in Patients With Unresectable Stage III Non-small Cell Lung Cancer
Sponsor:
Shandong Cancer Hospital and Institute
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2020-11-12
Start Date Type:
ACTUAL
Primary Completion Date:
2021-11-20
Primary Completion Date Type:
ACTUAL
Completion Date:
2021-11-22
Completion Date Type:
ACTUAL
First Submit Date:
2020-08-25
First Submit QC Date:
None
Study First Post Date:
2021-07-12
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2022-02-09
Last Update Post Date:
2022-02-25
Last Update Post Date Type:
ACTUAL